Lv1
50 积分 2025-12-28 加入
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity
27天前
已完结
Decoding disease-relevant variants with base and prime editors at scale
28天前
已完结
Molecular mechanisms and emerging therapeutics in pulmonary fibrosis: A recent update
29天前
已完结
Structure-Guided Optimization of p62-Directed AUTOTACs for Efficient EGFR/VEGFR2 Degradation and Antitumor Efficacy
1个月前
已完结
Inhalable Polymeric PROTAC Nanococktail for Targeted Protein Degradation in Idiopathic Pulmonary Fibrosis
1个月前
已完结
Inhalable Polymeric PROTAC Nanococktail for Targeted Protein Degradation in Idiopathic Pulmonary Fibrosis
1个月前
已完结
Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectives
2个月前
已完结
A PROTAC‐Based Cuproptosis Sensitizer in Lung Cancer Therapy
3个月前
已完结
Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis
3个月前
已完结
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
3个月前
已完结
皖公网安备34019202002308
